Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature
Genes · 2024
DOI: 10.3390/genes15091191 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Marta Arrabito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Pediatric Hematology Oncology, Azienda Policlinico di Catania, 95100 Catania, Italy. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Noonan Syndrome, Leukemia, Myelomonocytic, Juvenile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, IBISCUS onlus, AIRC.
Abstract (Originalsprache)
Noonan syndrome (NS) is an autosomal dominant disorder that varies in severity and can involve multiple organ systems. In approximately 50% of cases, it is caused by missense mutations in the PTPN11 gene (12q24.13). NS is associated with a higher risk of cancer occurrence, specifically hematological disorders. Here, we report a case of a child who was diagnosed at birth with a transient myeloproliferative disorder (TMD). After two years, the child developed hyperdiploid B-cell precursor acute lymphoblastic leukemia (BCP-ALL), receiving a two-year course of treatment. During her continuous complete remission (CCR), a heterozygous germline mutation in the PTPN11 gene [c.218 C>T (p.Thr73lle)] was identified. At the age of ten, the child presented with massive splenomegaly, hyperleukocytosis, and thrombocytopenia, resulting in the diagnosis of juvenile myelomonocytic leukemia (JMML). After an initial response to antimetabolite therapy (6-mercaptopurine), she underwent haploidentical hematopoietic stem cell transplantation (HSCT) and is currently in complete remission. The goal of this review is to gain insight into the various hematological diseases associated with NS, starting from our unique case.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Pediatric Hematology Oncology, Azienda Policlinico di Catania, 95100 Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy.
- School of Medical Genetics, University of Catania, 95100 Catania, Italy.
- Cytogenetic-Cytofluorimetric-Molecular Biology Lab, Center of Pediatric Hematology Oncology, Azienda Policlinico di Catania, Via Santa Sofia 78, 95123 Catania, Italy.
- School of Pediatrics, University of Catania, 95100 Catania, Italy.
ORCID-Profile: Giovanna Russo, Andrea Di Cataldo, Luca Lo Nigro
Förderung
- Italian Association for Cancer Research
- IBISCUS onlus
- AIRC
Zitieren
APA
Arrabito, M., Li Volsi, N., La Rosa, M., Samperi, P., Pulvirenti, G., Cannata, E., Russo, G., Di Cataldo, A., & Lo Nigro, L. (2024). Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature. Genes. https://doi.org/10.3390/genes15091191
Vancouver
Arrabito M, Li Volsi N, La Rosa M, Samperi P, Pulvirenti G, Cannata E, et al. Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature. Genes. 2024. doi:10.3390/genes15091191
BibTeX
@article{Arrabito2024,
author = {Arrabito, Marta and Li Volsi, Nicolò and La Rosa, Manuela and Samperi, Piera and Pulvirenti, Giulio and Cannata, Emanuela and Russo, Giovanna and Di Cataldo, Andrea and Lo Nigro, Luca},
title = {Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15091191}
}
EUVIMED